SEC Issues Charges Over Penny Stock Fraud
The SEC has charged a former microcap company CEO and a boiler-room operator with defrauding seniors and others.
All Work
Chris Lange
Tabula Rasa Healthcare Updates Expected IPO Pricing
Tabula Rasa Healthcare intends to price more than 4 million shares in the range of $13 to $15 per share in an initial public offering valued up to $74 million.
Fulgent Genetics Announces Potential Pricing for IPO
Fulgent Genetics expects to offer more than 4 million shares in an expected price range of $12 to $14 per share in an initial public offering valued up to about $74 million.
Social Media Short Sellers Raise the Stakes
The September 15 short interest data have been compared with the previous report, and short interest was up across the board in these selected social media stocks.
Cybersecurity Short Sellers Get More Selective
The September 15 short interest data have been compared with the previous figures, and short interest moves for the selected cybersecurity stocks were mixed.
Short Sellers Increase Bets in Major Biotechs
The September 15 short interest data have been compared with the previous report, and short interest moves were upward across most of these selected biotech stocks.
Is Major Semiconductor Short Interest Signaling an End to the Tech Rally?
Currently the markets are retreating, begging the question whether the recent tech rally is over. The short interest might suggest that it is.
Major Pharma Continues to See Rising Tide in Short Interest
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
Short Sellers Run for Cover From Major Oil
The September 15 short interest data have been compared with the previous figures, and short interest for the selected oil stocks was largely down.
Yum Announces Separation of Its China Business and Raises Dividend
Yum Brands has announced that it is spinning off its China business. The newly split company will be known as Yum China Holdings. At the same time, the company announced an increase in its…
Cal-Maine Whiffs on Q1 Earnings
Cal-Maine Foods fiscal first quarter was a disaster on both the top and bottom lines, primarily due to a very weak shell egg market.
Pfizer Decides Against the Split
Pfizer shares traded down marginally Monday morning after the company announced that it will abandon its plan to split into two companies.
Lanxess Moves to Acquire Chemtura
Shares of Chemtura saw a solid gain in Monday’s session after the company announced its acquisition by Lanxess.
4 Biopharma Companies Moving on Monday Ahead of the Presidential Debate
24/7 Wall St. has picked out some of the major companies in the health care sector that are moving ahead of the first presidential debate and added in some color for each.
Top 6 Earnings to Look for This Coming Week
24/7 Wall St. has put together a preview of Nike, PepsiCo and some of the major companies reporting their quarterly results this week.
5 Companies That Destroyed Shareholders Last Week
24/7 Wall Street has taken a look at Ascena Retail, Eleven Biotherapeutics and a few others companies posting the largest losses for the week.
Could Puma Biotech Double After This FDA Approval?
Puma Biotechnology posted strong gains over the course of this past week, which began with some positive news from the FDA and continued with a huge analyst call.
What Analysts Are Saying After Adobe’s Record Earnings Report
After Adobe released its fiscal third-quarter earnings report on Tuesday, the stock hit new all-time highs, and analysts even took this opportunity to chase Adobe higher.
Could Amazon.com Rise Another 25%?
Jeff Bezo’s brainchild has a growth engine that appears to be unmatched, but despite this Amazon stock has been difficult to time in terms of its valuation.
Endo Shuffles the Deck With New CEO Appointment
Shares of Endo International saw a handy gain in Friday’s session after the company named its new president and chief executive officer.